BDMD — BAIRD MED INVT HLDGS LTD
As of Q2 2026, 5 SEC-registered investment managers reported holding BDMD (BAIRD MED INVT HLDGS LTD) in their latest 13F filings, with a combined reported value of $280.66K across 244.05K shares. That is -14.3% by share count (-40.84K shares) versus the previous quarter, while reported value moved -48.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BDMD is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| JPMorgan Chase & Co history | Q1 2026 | 125.00K | $230.00K | 0.02% | New |
| Northern Trust Corp history | Q3 2025 | 48.29K | $102.37K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 58.69K | $67.49K | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 55.50K | $63.83K | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 55.37K | $63.68K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 54.90K | $63.13K | 0.00% | New |
| Morgan Stanley history | Q1 2026 | 20.00K | $39.20K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 19.60K | $22.54K | 0.00% | Reduce |
New Positions (Q2 2026)
- Renaissance Technologies 55.37K sh · $63.68K
- Citadel Advisors 54.90K sh · $63.13K
Fully Exited (vs previous quarter)
- JPMorgan Chase & Co sold 125.00K sh · $230.00K
- Morgan Stanley sold 20.00K sh · $39.20K
Fund Position History — shares by quarter (top 8 funds)
| Fund | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|
| UBS Group AG | 1.41K | 56.94K | 91.45K | 65.82K | 33.91K | 67.86K | 58.69K |
| Two Sigma Investments | — | — | — | — | 95.44K | 46.59K | 55.50K |
| Renaissance Technologies | — | — | — | — | — | — | 55.37K |
| Citadel Advisors | — | — | — | 46.53K | 112.66K | — | 54.90K |
| Geode Capital Management | 10.84K | 15.93K | 25.44K | 25.44K | 25.44K | 25.44K | 19.60K |
| Morgan Stanley | — | 13.17K | 8.73K | — | — | 20.00K | — |
| JPMorgan Chase & Co | — | — | — | — | — | 125.00K | — |
| Northern Trust Corp | — | — | 52.44K | 48.29K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details